Health CarePharmaceuticals and Biotechnology
  • Price (EUR)3.92
  • Today's Change0.048 / 1.24%
  • Shares traded8.94k
  • 1 Year change+20.47%
  • Beta1.2436
Data delayed at least 15 minutes, as of Oct 04 2022 08:47 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

As of last trade Genfit SA (GNFT:PAR) traded at 3.92, -20.81% below its 52-week high of 4.95, set on Dec 17, 2021.
52-week range
2.75Dec 07 20214.95Dec 17 2021
Markit short selling activity
Previous close3.87
Average volume152.50k
Shares outstanding49.82m
Free float43.23m
P/E (TTM)3.52
Market cap187.51m EUR
EPS (TTM)1.07
Data delayed at least 15 minutes, as of Oct 04 2022 08:47 BST.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.